Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG)

CAPS Rating: 2 out of 5

The Company is seeking to develop and commercialize new diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs.

Recs

0
Player Avatar pchop123 (76.62) Submitted: 8/17/2012 1:47:40 PM : Outperform Start Price: $3.93 ROSG Score: +59.36

dipped on dilution, so I want to partake in the upside now

Featured Broker Partners


Advertisement